T1	Participants 33 69	threshold retinopathy of prematurity
T2	Participants 615 719	enrolled under a prospective, randomized protocol. One eye of each patient with symmetric, threshold ROP
T3	Participants 913 1204	Nineteen infants (33 eyes) were treated, ranging from 485 to 863 g birth weight (23 to 27 weeks gestational age); 18 patients (32 eyes) were followed for 3 months or longer. Four patients (8 eyes) had bilateral zone 1 disease. Postconceptional age was 36 to 45 weeks at the time of treatment
